title: Dose wisely! How lipid-lowering undertreatment can lead to overtreatment.
authors: Research Unit of Lipids and Atherosclerosis, University Rovira i Virgili, C. Sant Llorenç 21, 43201, Reus, Spain. Electronic address: luis.masana@urv.cat.
authors: Luis
authors: L
authors: Masana
authors: Department of Internal Medicine, Division Vascular Medicine, Erasmus MC, Rotterdam, The Netherlands.
authors: Jeanine Roeters van
authors: JRV
authors: Lennep
mesh_terms: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D008055:Lipids; D000069342:Medical Overuse; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D008055:Lipids; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases
keywords: LDL cholesterol; LDL targets; Lipid lowering therapy; PCSK9 inhibitors; Treatment adherence; Undertreatment